To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Wellspring Capital snags specialty infusion company Pentec Health
The New York firm looks to unlock more value at a $30 million-in-EBITDA platform comprising a chronic pain management and renal nutrition business.
